Clinical Trial Update: Depsipeptide in Treating Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating depsipeptide (romidepsin) in lymphoma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Romidepsin (Depsipeptide) (romidepsin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma | Phase 1 | Status: COMPLETED